EMPLOYMENT AGREEMENTEmployment Agreement • February 28th, 2022 • Aspira Women's Health Inc. • In vitro & in vivo diagnostic substances • Connecticut
THIS EMPLOYMENT AGREEMENT (this “Agreement”) between Aspira Women’s Health Inc., a Delaware corporation (the “Company”), and Nicole Sandford (“Executive,” and together with the Company, the “Parties”) is effective as of March 1, 2022 (the “Effective Date”).
AMENDED & RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • February 28th, 2022 • Aspira Women's Health Inc. • In vitro & in vivo diagnostic substances • Connecticut
THIS AMENDED & RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) between Aspira Women’s Health Inc., a Delaware corporation (the “Company”), and Valerie B. Palmieri (“Executive,” and together with the Company, the “Parties”) is effective as of March 1, 2022 (the “Effective Date”). This Agreement amends and restates the Employment Agreement between the Parties, dated January 1, 2015.
